Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. [Phase 3]
An update on a Phase 3 trial evaluating fenofibrate for microvascular eye complications in Type 1 diabetes shows the study is currently acti…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes. [NA]
A clinical trial is studying an oral uremic toxin absorbent combined with probiotics to modulate systemic inflammation and slow the progress…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes [Phase 1, Phase 2]
A Phase 1/2 trial evaluating metabolic surgery in youths with type 2 diabetes and obesity to assess pancreatic, renal, and cardiovascular he…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Resveratol in Diabetic Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Resveratol for diabetic nephropathy sponsored by Ain Shams University has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease [NA]
This clinical trial update notes the completion of a study evaluating a Basic Needs Navigation Intervention for African Americans with diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
This clinical trial update indicates that the study is currently recruiting to assess the prevalence and predictive factors of diabetic neph…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study [Phase 4]
A Phase IV feasibility study evaluating whether urinary proteomics can guide early intervention to prevent complications in type 2 diabetes …
-
FDA approval · 2025-12-16FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' Losartan Potassium (generic Losartan Potassium). The approval authorizes…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Type 2 Diabetes and Associated Factors in Mexico
A clinical trial investigating Type 2 diabetes and associated factors in Mexico is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus [NA]
This clinical trial update indicates ongoing recruitment for a study evaluating non-surgical periodontal therapy and its effects on kidney o…
-
FDA approval · 2025-11-25FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for irbesartan filed by NorthStar RxLLC under ANDA 202254, authorizing changes to the product's appr…
-
FDA approval · 2025-11-12FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for IRBESARTAN (irbesartan) from Aurobindo Pharma Limited. This action approves changes under the AN…
-
FDA approval · 2025-09-30FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for IRBESARTAN submitted by Camber Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients [NA]
A completed clinical trial comparing high-intensity laser exercise to moderate-intensity aerobic exercise in patients with diabetes-related …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases [Phase 4]
Phase 4 clinical trial update for ACE Reno and Pico Cell Matrix evaluating effects on estimated glomerular filtration rate in chronic kidney…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: May Metformin be Used in Renal Failure? [Phase 2]
A Phase 2 trial evaluating the safety of metformin in patients with renal impairment associated with type 2 diabetes has been completed.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
This document outlines a protocol to evaluate novel inflammatory markers and MCP-1 in Type 2 diabetic nephropathy. The study is not yet recr…
-
CLINICAL_TRIALS withdrawal · 2025-08-17Clinical Trial Update: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease [Phase 1]
Phase 1 trial evaluating patient-derived autologous stem cell therapy for diabetic kidney disease was terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy [NA]
A completed clinical trial evaluated the efficacy and safety of a novel Tripterygium wilfordii preparation for reducing proteinuria in diabe…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Atrasentan in Patients With Proteinuric Glomerular Diseases [Phase 2]
Phase 2 trial of atrasentan for proteinuric glomerular diseases is active but not recruiting, including IgA nephropathy, Focal segmental glo…
-
FDA approval · 2025-08-01FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population
This clinical trial from Astana Medical University investigates genome-associated mechanisms of diabetic nephropathy and evaluates a nephrop…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Stem Cell Therapy for Chronic Kidney Disease [Phase 1]
This update reports results from a Phase 1 trial of a stem cell therapy for chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Effects of PH3 in Diabetic Nephropathy [Phase 2]
Phase 2 clinical trial evaluating PH3 for diabetic nephropathy has completed; the provided information does not include trial results.